Canterbury DHB


CLL, HCL, & LGL Leukaemia

This chapter was updated in September 2018. Most aspects of management are consistent with those described in the most recent guideline by the International Workshop on CLL, with adaptation to local practices and constraints. Where practice has changed, this is reflected in newer references within each section. It is next due for review in September 2021.

In This Section

Mature B-cell Leukaemias

Mature T- and NK-Cell Leukaemias

About this Canterbury DHB document (5684):

Document Owner:

Blake Hsu (see Who's Who)

Last Reviewed:

September 2018

Next Review:

September 2021


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 5684